Session Information
Session Title: AA 2022 Posters - General Rehabilitation
Session Time: None. Available on demand.
Disclosures: Samir A. Khan, DO: No financial relationships or conflicts of interest
Objective: To test the hypotheses that oral cranberry supplementation (OCS) will decrease the incidence of Escherichia coli urinary tract infections (UTIs) in an inpatient stroke rehabilitation population, by acting as a prophylactic agent.
Design: Retrospective cohort study
Setting: Academic inpatient rehabilitation hospital, Stroke service
Participants: 176 consecutive patients over an 8-month period
Interventions: We started oral cranberry extract 300mg BID to all patients upon admission, except those patients on warfarin, with transplanted organs, or who declined.
Main Outcome Measures: Incidence of E.coli UTI when on OCS vs. not on OCS
Results: For patients on OCS (n=133) over an 8-month period, the incidence rate of E.coli UTI was 4.5% (6/133, 95% CI [1.7, 9.6]). During this timeframe, for patients not on OCS (n=43) the incidence rate of E.coli UTI was 2.3% (1/43, 95% CI [.06, 12.3]). This difference was not statistically significant (p=0.52).
Conclusions: OCS monotherapy did not significantly impact the incidence of E.coli UTI in an inpatient stroke rehabilitation population.
Level of Evidence: Level III
To cite this abstract in AMA style:
Khan SA, Mansourian V, Abramson N, Sturdivant A. Cranberry Supplementation for E.coli UTI Prophylaxis in Inpatient Stroke Rehabilitation: A Retrospective Analysis [abstract]. PM R. 2022; 14(S1)(suppl 1). https://pmrjabstracts.org/abstract/cranberry-supplementation-for-e-coli-uti-prophylaxis-in-inpatient-stroke-rehabilitation-a-retrospective-analysis/. Accessed May 18, 2025.« Back to AAPM&R Annual Assembly 2022
PM&R Meeting Abstracts - https://pmrjabstracts.org/abstract/cranberry-supplementation-for-e-coli-uti-prophylaxis-in-inpatient-stroke-rehabilitation-a-retrospective-analysis/